Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2014 Jul 30;16(16):4098–4101. doi: 10.1021/ol501789c

Asymmetric One-Pot Synthesis of 1,3-Oxazolidines and 1,3-Oxazinanes via Hemiaminal Intermediates

Sri Krishna Nimmagadda 1, Zuhui Zhang 1, Jon C Antilla 1,*
PMCID: PMC4136672  PMID: 25075467

Abstract

graphic file with name ol-2014-01789c_0006.jpg

A highly efficient method for the enantioselective one-pot synthesis of 1,3-oxazolidines and 1,3-oxazinanes has been reported. The reaction proceeds via the formation of hemiaminal intermediates obtained by the enantioselective addition of respective alcohols to imines catalyzed by a chiral magnesium phosphate catalyst, followed by intramolecular cyclization under mildly basic conditions. A wide range of substrates have been converted to the respective chiral heterocyclic products in high yields and with excellent enantioselectivities using this one-pot procedure.


Chiral oxazolidines are important structural moieties that exist in many biologically active compounds.1 The 1,3-oxazolidine ring is present in polycyclic tetrahydroisoquinoline alkaloids such as quinocarcin and its analogue terazomine, both of which have antitumor activity.1,2 They are widely used in asymmetric synthesis3 as chiral auxiliaries3a in reactions that include cyclopropanation,3b Grignard reaction,3c epoxidation,3d 1,3-dipolar cycloadditions,3e intramolecular Diels–Alder reaction,3f and hydrogenation.3g 1,3-Oxazolidines are also used as chiral ligands for transition metal catalysts in asymmetric catalysis.4 Generally, oxazolidines are prepared by the condensation of chiral 1,2-amino alcohols with aldehydes, ketones, or oxo compounds.4 These methods involve the use of chiral reagents and stoichiometric equivalents of catalysts. Yoon et al. described copper catalyzed aminohydroxylation of styrenes and oxyamination of olefins using an iron catalyst for the enantioselective synthesis of 1,3-oxazolidines.5 Recently, Jarvo et al. developed transition metal catalyzed stereospecific and stereoconvergent methods to synthesize chiral 1,3-oxazolidines.6 In addition, Du and co-workers reported rhodium catalyzed cycloaddition reactions of racemic butadiene monoxide with imines.7 Wang et al. proposed an interesting approach to synthesize benzoxazoles via organocatalytic [4 + 1] annulation, but with poor enantiocontrol.8 Herein, we report the chiral magnesium phosphate catalyzed asymmetric one-pot synthesis of chiral 1,3-oxazolidines with high yields and excellent enantioselectivity.

Over the past decade, chiral phosphoric acids9 and metal complexes of chiral phosphates10 have been used as effective catalysts in various asymmetric transformations.11 In 2008, our group reported the enantioselective addition of alcohols to imines using 3,3′-9-anthryl-BINOL phosphoric acid.12 To further expand the utility of this methodology, we envisioned the possible synthesis of chiral 1,3-oxazolidines (Figure 1) by cyclization through intramolecular nucleophilic substitution in 5-exo-tet fashion, in accordance with Baldwin’s rules.13

Figure 1.

Figure 1

Intrigued by the reports of Ishihara,10a10c List,10d and the recent results from our group on chiral BINOL phosphates,10e10h,10k we initiated optimization of the catalyst with the use of chiral phosphoric acids and their metal phosphate complexes as possible catalysts. Interestingly, 9-anthryl derived BINOL phosphoric acid gave a very low ee (Table 1, entry 1). This prompted us to explore alkali and alkaline-earth metal complexes of chiral phosphates. Ca[P1]2 gave a good yield but showed very poor selectivity (Table 1, entry 2), while with Mg[P1]2 the product is formed with high yield and enantioselectivity. We observed that a 3,3′-triisopropyl derived BINOL phosphate metal complex also gave the product in high yield and enantioselectivity. Clearly, Mg[P2]2 has proven to be the best catalyst (Table 1, entry 5) with excellent selectivity, whereas Ca, Li, Al, Zn, Sr complexes of the 3,3′-triisopropyl derived BINOL phosphate showed moderate enantioselectivities (entries 4, 6–9).

Table 1. Optimization of Reaction Conditionsa.

graphic file with name ol-2014-01789c_0004.jpg

entry catalyst yield (%)b ee (%)c
1 H[P1] 73 7
2 Ca[P1]2 91 10
3 Mg[P1]2 90 95
4 Ca[P2]2 70 68
5 Mg[P2]2 90 97
6 Li[P2]2 94 66
7 Al[P2]3 90 40
8 Zn[P2]2 95 74
9 Sr[P2]2 98 74
a

Reaction conditions: 1a (1.0 equiv), 2 (2.0 equiv), 2.5 mol % catalyst, ethyl acetate (1 mL), and 4 Å MS 40 mg/mL.

b

Isolated yield.

c

Determined by chiral HPLC analysis.

A brief screening of bases was performed for the intramolecular cyclization of 3a. We observed that K3PO4, DBU, and Cs2CO3 in ethyl acetate did not lead to the cyclized product 4a. By using the more reactive substrate 3b with bromide as the leaving group, the desired transformation was provided with bases DBU and KOtBu in good yields. But the highest enantioselectivity we observed for 3b was 65% (Table 2, entries 5,6). Interestingly, Cs2CO3 gave product 4a in high yield retaining the selectivity (Table 2, entry 7).

Table 2. Optimization of Reaction Conditions for the Intramolecular Cyclizationa.

graphic file with name ol-2014-01789c_0005.jpg

entry X base yield (%)b ee of 3 (%)c ee of 4a (%)c
1 Cl K3PO4 10 95 ND
2 Cl DBU 0 95 ND
3 Cl Cs2CO3 0 95 ND
4 Br DMAP 0 65 ND
5 Br DBU 82 65 22
6 Br KOtBu 86 65 57
7 Br Cs2CO3 90 65 65
8d Cl KOtBu 71 95 84
9e,f Cl Cs2CO3 97 93 93
a

Reaction Conditions: 3 (1.0 equiv), base (4.0 equiv), ethyl acetate.

b

Isolated yield.

c

Determined by chiral HPLC analysis.

d

THF used as solvent.

e

DMF used as solvent.

f

Base added at 0 °C.

To our delight, optimization of solvents using 3a with bases of varied strength furnished the desired product in good yield. With KOtBu as the base the reaction showed little loss in selectivity, whereas Cs2CO3 at 0 °C produced 4a in high yield with retention of selectivity. Presumably, a strong base would also interact with the acidic proton on carbon and hence lower the selectivity of the cyclized product. Clearly, cyclization of 3a using Cs2CO3 in DMF is the ideal condition for the formation of 4a in high yield with excellent enantioselectivity (entry 9).

To further investigate the scope of this reaction in one pot, we performed the reaction from 3a to 4a in ethyl acetate as solvent. Unfortunately, the reaction did not proceed to completion (Table 2, entry 3). Alternatively, we tried the transformation from 1a to 3a in DMF using optimized conditions, but a racemic product was obtained. On the basis of these observations, after formation of 3a, we concentrated the reaction by removing the solvent and then added DMF and Cs2CO3. Compound 4a was then obtained in one pot in high yield with excellent retention of enantioselectivity.

Under the optimized conditions, we examined a wide variety of imine substrates. The products were obtained in good yield with excellent enantioselectivities (Figure 2). The results showed that the substituents, both electron-donating and -withdrawing groups, at the para position on the phenyl ring of imines had little effect on the enantioselectivity. Electron-withdrawing groups at the meta position on the phenyl ring (4d) showed excellent selectivity compared to the electron-releasing methyl group (4i). The absolute configuration was determined by HPLC comparison of the product 3a to the literature.11

Figure 2.

Figure 2

Catalytic asymmetric synthesis of 1,3-oxazolidines. Experimental conditions: 1a (1.0 equiv), 2 (2.0 equiv), 2.5 mol % catalyst, ethyl acetate, and 4 Å MS 40 mg/mL. Ethyl acetate was removed before step 2, and DMF and Cs2CO3 (2.0 equiv) were added. All yields are isolated. The ee was determined by chiral HPLC analysis.

We further envisaged the possible synthesis of chiral 1,3-oxazinanes14 using the optimized methodology. The hemiaminal intermediate formed by the addition of 3-chloropropanol to 1a was obtained with high selectivity, but after cyclization with Cs2CO3 a racemic product was observed. A series of experiments were conducted with 3-chloropropanol using different bases and different temperature variations which showed no effect on retaining selectivity. To our delight, the use of more reactive 3-bromopropanol favored the formation of six membered products with moderate to good enantioselectivities and high yields. Both electron-releasing and -withdrawing substituents on the phenyl ring were tolerated (Figure 3).

Figure 3.

Figure 3

Catalytic asymmetric synthesis of 1,3-oxazinanes. Experimental conditions: 1a (1.0 equiv), 5 (2.0 equiv), 5 mol % catalyst, ethyl acetate, and 4 Å MS 40 mg/mL. Ethyl acetate was removed before step 2, and DMF and Cs2CO3 (2.0 equiv) were added. All yields are isolated. The ee was determined by chiral HPLC analysis.

In summary, the one-pot synthesis of chiral 1,3-oxazolidines and chiral 1,3-oxazinanes by 9-anthryl derived chiral BINOL magnesium phosphate catalyzed enantioselective addition of alcohol to imines followed by 5-exo-tet cyclization and 6-exo-tet cyclization of hemiaminal intermediates under mild basic conditions has been successfully achieved with high yields and excellent enantioselectivities.

Acknowledgments

We thank the National Institutes of Health (NIH GM-082935) and the National Science Foundation (NSF-0847108) for financial support.

Supporting Information Available

Experimental conditions, characterization data, and spectra for all compounds. This material is available for free of charge via Internet at http://pubs.acs.org.

The authors declare no competing financial interest.

Funding Statement

National Institutes of Health, United States

Supplementary Material

ol501789c_si_001.pdf (189.5KB, pdf)
ol501789c_si_002.pdf (4.3MB, pdf)

References

  1. For a review on tetrahydroisoquinoline natural products, see:Scott J. D.; Williams R. M. Chem. Rev. 2002, 102, 1669. [DOI] [PubMed] [Google Scholar]
  2. a Williams R. M.; Glinka T.; Flanagan M. E.; Gallegos R.; Coffman H.; Pei D. J. Am. Chem. Soc. 1992, 114, 733. [Google Scholar]; b Tomita F.; Takahashi K.; Tamaoki T. J. Antibiot. 1984, 37, 1268. [DOI] [PubMed] [Google Scholar]
  3. For selected examples, see:; a Agami C.; Couty F. Eur. J. Org. Chem. 2004, 677. [Google Scholar]; b Bernardi A.; Scolastico C.; Villa R. Tetrahedron Lett. 1989, 30, 3733. [Google Scholar]; c Isobe M.; Hirose Y.; Shimokawa K.; Nishikawa T.; Goto T. Tetrahedron Lett. 1990, 31, 5499. [Google Scholar]; d Cardani S.; Gennari C.; Scolastico C.; Villa R. Tetrahedron 1989, 45, 7397. [Google Scholar]; e Lacoste J.-E.; Soucy C.; Rochon F. D.; Breau L. Tetrahedron Lett. 1998, 39, 9121. [Google Scholar]; f Jung M. E.; Street L. J. Heterocycles 1988, 27, 45. [Google Scholar]; g Bernardi A.; Carugo O.; Pasquarello A.; Sidjimov A.; Poli G. Tetrahedron 1991, 47, 7357. [Google Scholar]
  4. For review, see:Wolf C.; Xu H. Chem. Commun. 2011, 47, 3339. [DOI] [PubMed] [Google Scholar]
  5. a Michaelis D. J.; Ischay M. A.; Yoon T. P. J. Am. Chem. Soc. 2008, 130, 6610. [DOI] [PubMed] [Google Scholar]; b Michaelis D. J.; Williamson K. S.; Yoon T. P. Tetrahedron 2009, 5118. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Williamson K. S.; Yoon T. P. J. Am. Chem. Soc. 2010, 132, 4570. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Williamson K. S.; Yoon T. P. J. Am. Chem. Soc. 2012, 134, 12370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Shaghafi M. B.; Grote R. E.; Jarvo E. R. Org. Lett. 2011, 13, 5188. [DOI] [PubMed] [Google Scholar]
  7. Liu Z.; Feng X.; Du H. Org. Lett. 2012, 14, 3154. [DOI] [PubMed] [Google Scholar]
  8. Song A.; Chen X.; Song X.; Zhang X.; Zhang S.; Wang W. Org. Lett. 2013, 15, 2510. [DOI] [PubMed] [Google Scholar]
  9. For selected reviews, see:; a Akiyama T.; Itoh J.; Fuchibe K. Adv. Synth. Catal. 2006, 348, 999. [Google Scholar]; b Akiyama T. Chem. Rev. 2007, 107, 5744. [DOI] [PubMed] [Google Scholar]; c Doyle A. D.; Jacobsen E. N. Chem. Rev. 2007, 107, 5713. [DOI] [PubMed] [Google Scholar]; d Terada M. Chem. Commun. 2008, 4097. [DOI] [PubMed] [Google Scholar]; e Terada M. Synthesis 2010, 1929. [Google Scholar]; f Terada M. Bull. Chem. Soc. Jpn. 2010, 83, 101. [Google Scholar]; g Terada M. Curr. Org. Chem. 2011, 15, 2227. [Google Scholar]; h Rueping M.; Kuenkel A.; Atodiresei I. Chem. Soc. Rev. 2011, 40, 4539. [DOI] [PubMed] [Google Scholar]
  10. a Hatano M.; Ikeno T.; Matsumura T.; Torii S.; Ishihara K. Adv. Syn. Catal. 2008, 350, 1776. [Google Scholar]; b Shen K.; Liu X.; Cai Y.; Lin; Feng X. Chem.—Eur. J. 2009, 15, 6008. [DOI] [PubMed] [Google Scholar]; c Hatano M.; Moriyama K.; Maki T.; Ishihara K. Angew. Chem., Int. Ed. 2010, 49, 3823. [DOI] [PubMed] [Google Scholar]; d Klussmann M.; Ratjen L.; Hoffmann S.; Wakchaure V.; Goddard R.; List B. Synlett 2010, 2189. [Google Scholar]; e Zhang Z.; Zheng W.; Antilla J. C. Angew. Chem., Int. Ed. 2011, 50, 1135. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Zheng W.; Zhang Z.; Kaplan M. J.; Antilla J. C. J. Am. Chem. Soc. 2011, 133, 3339. [DOI] [PMC free article] [PubMed] [Google Scholar]; g Ingle G. K.; Liang Y.; Mormino M.; Li G.; Fronczek F. R.; Antilla J. C. Org. Lett. 2011, 13, 2054. [DOI] [PMC free article] [PubMed] [Google Scholar]; h Larson S. E.; Li G.; Rowland G. B.; Junge D.; Huang R.; Woodcock H. L.; Antilla J. C. Org. Lett. 2011, 13, 2188. [DOI] [PMC free article] [PubMed] [Google Scholar]; i Alix A.; Lalli C.; Retailleau P.; Masson G. J. Am. Chem. Soc. 2012, 134, 10389. [DOI] [PubMed] [Google Scholar]; j Shi S.; Huang F.; Zhu P.; Dong Z.; Hui X. Org. Lett. 2012, 14, 2010. [DOI] [PubMed] [Google Scholar]; k Li G.; Liang T.; Wojtas L.; Antilla J. C. Angew. Chem. Int. Ed 2013, 52, 4628. [DOI] [PubMed] [Google Scholar]
  11. For a recent review, see:Yamashita Y.; Tsubogo T.; Kobayashi S. Chem. Sci. 2012, 3, 967. [Google Scholar]
  12. Li G.; Fronczek F. R.; Antilla J. C. J. Am. Chem. Soc. 2008, 130, 12216. [DOI] [PubMed] [Google Scholar]
  13. Baldwin J. E. J. Chem. Soc., Chem. Commun. 1976, 734. [Google Scholar]
  14. For synthesis and biological importance of 1,3-oxazinanes, see:; a Mino T.; Hata S.; Ohtaka K.; Sakamoto M.; Fujita T. Tetrahedron Lett. 2001, 42, 4837. [Google Scholar]; b Groth T.; Meldal M. J. Comb. Chem. 2001, 3, 34. [DOI] [PubMed] [Google Scholar]; c Diness F.; Beyer J.; Meldal M. QSAR Comb. Sci. 2004, 23, 130. [Google Scholar]; d Wang X.; Dong Y.; Sun J.; Xu X.; Li R.; Hu Y. J. Org. Chem. 2005, 70, 1897. [DOI] [PubMed] [Google Scholar]; e Zanatta N.; Squizani A. M. C.; Fantinel L.; Nachtigall F. M.; Borchhardt D. M.; Bonacorso H. G.; Martins M. A. P. J. Brazil. Chem. Soc. 2005, 16, 1255. [Google Scholar]; f Ghorai M. K.; Das K.; Kumar A. Tetrahedron Lett. 2007, 48, 4373. [Google Scholar]; g D’hooghe M.; Dekeukeleire S.; Mollet K.; Lategan C.; Smith P. J.; Chibale K.; Kimpe N. D. J. Med. Chem. 2009, 52, 4058. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ol501789c_si_001.pdf (189.5KB, pdf)
ol501789c_si_002.pdf (4.3MB, pdf)

Articles from Organic Letters are provided here courtesy of American Chemical Society

RESOURCES